Can food antigens stimulate intestinal secretory IgA and low-grade mucosal immune activation in susceptible individuals?

Dietary antigens act as constant immunological stimuli within the gastrointestinal tract. In a healthy gut, this interaction promotes immunological tolerance and barrier defense, whereas in susceptible individuals, it can trigger localized inflammatory cascades.

Mucosal sIgA stimulation and barrier defense

• sIgA upregulation: Mucosal exposure to food antigens directly stimulates secretory IgA (sIgA) production. This response is well-documented in animal models (such as piglets fed soybean antigen-rich diets) and in humans undergoing oral immunotherapy.
• Immune exclusion: Under homeostatic conditions, sIgA serves as a critical first-line barrier molecule that binds and neutralizes lumenal food proteins, physically restricting their transit across the intestinal epithelium to prevent inflammatory cascades.

Low-grade immune activation in susceptible hosts

• Epithelial barrier compromise: In individuals with irritable bowel syndrome (IBS) or functional dyspepsia, compromised barrier integrity allows food antigens to bypass sIgA-mediated exclusion and penetrate the lamina propria.
• Inflammatory recruitment: Once inside the mucosa, food antigens interact directly with resident immune cells—specifically mast cells, eosinophils, and T cells—to drive localized, low-grade duodenal or colonic inflammation.

Mechanistic pathways of reactivity

• Regulatory role of sIgA: sIgA acts as a key regulatory molecule that actively dampens low-grade mucosal immune activation by limiting antigen penetration and directly inhibiting IgE-mediated mast cell activation.
• Mast cell degranulation: When oral tolerance is broken (often due to stress or prior infection), localized food-specific IgE binds to tissue-resident mast cells. Subsequent antigen exposure triggers mast cell degranulation, releasing histamine and driving visceral hypersensitivity.

Bottom line

• Food antigens stimulate protective sIgA to maintain intestinal homeostasis; however, in susceptible individuals with compromised gut barriers, these same antigens bypass immune exclusion to drive low-grade, mast-cell-mediated mucosal immune activation and visceral hypersensitivity.